Raia Drogasil stock, RD Saúde

Raia Drogasil stock posts stronger Q3 on pharmacy expansion

Published on 11/17/2026 at 02:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Raia Drogasil stock posted adjusted net income of 439.1 million Brazilian reais in Q3. Gross revenue rose 16.0 percent as the pharmacy network reached 3,770 stores.

Strong quarter, broader pharmacy network

  • Adjusted net income rose 9.2 percent year on year to 439.1 million Brazilian reais.
  • Gross revenue increased 16.0 percent, while digital sales climbed 27.2 percent.
  • RD Saúde reiterated its 2026 target of 330 to 350 gross pharmacy openings.
Raia Drogasil stock, RD Saúde, Q3 2026 results, pharmacy retail, Brazil equities, Illustration mit AI erstellt.

RD Saúde, formerly known as Raia Drogasil, reported its third-quarter 2026 results on November 3, 2026. Adjusted net income rose 9.2 percent year on year to 439.1 million Brazilian reais, according to the company's third-quarter results presentation.

Revenue growth across the network

Gross revenue rose 16.0 percent to 13.2 billion Brazilian reais. The company said national market share reached 19.1 percent, an increase of 1.1 percentage points, with gains across all regions.

Adjusted EBITDA increased 14.7 percent to 1.0237 billion Brazilian reais, while the adjusted EBITDA margin was 7.8 percent. Adjusted earnings before tax rose 31.0 percent to 547.6 million Brazilian reais.

Digital sales and expansion

Digital sales climbed 27.2 percent to 3.8 billion Brazilian reais and represented 29.4 percent of retail sales. The pharmacy network ended the quarter with 3,770 locations after 92 openings and nine closures during the period.

Management reiterated its 2026 target of 330 to 350 gross pharmacy openings. The company recorded 333 gross openings over the 12 months through the third quarter.

Brazilian pharmacy retail platform

RD Saúde operates the Raia and Drogasil pharmacy chains in Brazil, combining physical stores with digital sales channels. Its business serves consumers through prescription medicines, health products and everyday pharmacy retail. The company is expanding its store network while investing in omnichannel distribution and customer reach.

RD Saúde Q3 2026 facts

  • Company: RD Saúde, formerly Raia Drogasil
  • Quarter: Third quarter of 2026
  • Adjusted net income: 439.1 million Brazilian reais, up 9.2 percent year on year
  • Gross revenue: 13.2 billion Brazilian reais, up 16.0 percent
  • Adjusted EBITDA: 1.0237 billion Brazilian reais, up 14.7 percent
  • Pharmacies: 3,770 at the end of the quarter

Brazilian equities are part of the market environment tracked by the Bovespa market.

Disclaimer...
en | boerse | 70523550 |